GL
IONS icon

GLG LLC’s Ionis Pharmaceuticals IONS Stock Holding History

GLG LLC’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.15M Hold
22,874
– – 0.08% 238
2017
Q3 		$1.16M Buy
+22,874
New +$1.2M 0.08% 269

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

GLG LLC's IONS Position: Q4 2017 in Review

GLG LLC held its Ionis Pharmaceuticals (IONS) position steady in Q4 2017 at 22,874 shares worth $1.15M. The position accounts for 0.08% of the portfolio, ranked #238.

GLG LLC first reported a position in IONS in Q3 2017 and has held it in 2 quarters since. The position peaked at $1.16M in Q3 2017. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

  • GLG LLC held 22,874 shares of Ionis Pharmaceuticals worth $1.15M as of Q4 2017.
  • GLG LLC left its Ionis Pharmaceuticals share count unchanged in Q4 2017.
  • Ionis Pharmaceuticals made up 0.08% of GLG LLC's portfolio in Q4 2017, its #238 holding.
  • GLG LLC first reported a position in Ionis Pharmaceuticals in Q3 2017 and has held it in 2 quarters since.
  • GLG LLC's Ionis Pharmaceuticals position peaked at $1.16M in Q3 2017.
  • 316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.